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Abstract
Background: Bacteriophage treatment is a promising tool to reduce
Campylobacter in chickens. Several studies have been published where group II or
group III phages were successfully applied. However, these two groups of phages
are different regarding their host ranges and host cell receptors. Therefore, a
concerted activity of group II and group III phages might enhance the efficacy of a
treatment and decrease the number of resistant bacteria.
Results: In this study we have compared the lytic properties of some group II and
group III phages and analysed the suitability of various phages for a reduction of C.
jejuni in broiler chickens. We show that group II and group III phages exhibit
different kinetics of infection. Two group III and one group II phage were selected for
animal experiments and administered in different combinations to three groups of
chickens, each containing ten birds. While group III phage CP14 alone reduced
Campylobacter counts by more than 1 log10 unit, the concomitant administration of
a second group III phage (CP81) did not yield any reduction, probably due to the
development of resistance induced by this phage. One group of chickens received
phage CP14 and, 24 hours later, group II phage CP68. In this group of animals,
Campylobacter counts were reduced by more than 3 log10 units.
Conclusion: The experiments illustrated that Campylobacter phage cocktails have
to be carefully composed to achieve the best results.
Introduction
Campylobacteriosis is a worldwide zoonosis and the most frequent cause of
bacterial enteritis in the EU [1]. In the United States campylobacteriosis is
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estimated to affect more than two million persons every year at great expenses of
approximately $1.2 billion annually [2]. Typical symptoms of the disease are
diarrhea, cramping, abdominal pain, and fever. Even though a number of
pathogenic Campylobacter (C.) species have been identified, the thermophilic C.
jejuni and, to a lesser extent, also C. coli are responsible for the majority of cases of
campylobacterosis [3]. The infection is mainly caused by the consumption and
handling of contaminated, undercooked meats, especially poultry [4, 5].
Campylobacter is a common commensal of the gastrointestinal tract of various
mammals and birds [6]. It is frequently found in chicken farms where the bacteria
may spread rapidly [7]. Contaminated birds are shedding up to 108 Campylobacter
per gram of cecal contents. Hitherto implemented intervention strategies mainly
focus on on-farm biosecurity measures and post-slaughter decontamination of
poultry carcasses [8, 9]. It has been calculated that a reduction of Campylobacter
counts on carcasses by two orders of magnitudes could lead to a 30-fold decrease
in human campylobacteriosis [10]. However, measures to combat the agent are
expensive and not always efficient [11]. Moreover, suitable vaccines have not been
made available until now. For these reasons, bacteriophages (phages) have been
proposed to reduce the Campylobacter counts in chicken [12].
To date several small-scale studies have been performed to evaluate the
potential of phages for a reduction of Campylobacter in the broiler gut and on
chicken skin [9, 13–18]. In addition, the first field trial with Campylobacter phages
(campylophages) has recently been carried out in commercial broiler flocks [19].
In most of these studies, Campylobacter counts in cecal content could be reduced
by an average of two log10 units. In all these studies single phages or cocktails
composed of several phages belonging to the same group have been tested. On the
basis of their morphology, genome size and endonuclease restriction profile, the
currently known lytic Campylobacter phages are divided into three groups [20] of
which members of group II and group III have yet been used for applications.
Group II phages have generally a broader host range than phages of group III
since they frequently infect both C. jejuni and C. coli strains. On the other hand,
some group III phages isolated from poultry sources showed a strong lytic activity
on certain C. jejuni strains [17]. As phage resistance has been perceived as a
potential drawback to phage application, it is of great importance that group II
and group III phages apparently use multiple host cell receptors for binding
[21, 22]. Hence, to overcome the problem of phage resistance in Campylobacter, it
may be advisable to apply phages belonging to different groups.
In this study, we compared the host ranges and lytic properties of group II and
group III phages and used a new approach to achieve a reduction of C. jejuni in
broiler chicken. The efficacy of a combination of two phages belonging to group II
and group III was compared to that of an individual phage. Furthermore, we
determined the reduction of Campylobacter counts after simultaneous and
successive administration of different phages. Finally, resistance frequencies of
in vitro- and in vivo-infected bacteria were determined.
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Materials and Methods
Bacterial strains and growth conditions
Bacterial strains used in this study were obtained from the strain collection of the
National Collection of Type Cultures (NCTC, Health Protection Agency, UK) and
the National Reference Laboratory for Campylobacter of the Federal Institute for
Risk Assessment (BfR, Berlin, Germany) (Table 1). Most of the C. jejuni and C.
coli strains originated from the Campynet (CNET) strain collection hosted by the
Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures,
Braunschweig, Germany, (search term ‘‘campynet’’). Campylobacter spp. strains
were stored at 280 C˚ in 10% glycerol stocks. Cultivation of the bacteria was
performed on sheep blood agar (blood agar base No. 1, Oxoid, Dassel, Germany)
with 5% [vol/vol] defibrinated sheep blood under microaerobic conditions (5%
O2, 10% CO2, and rest N2) at 42 C˚ for 24 to 48 h [23]. Further cultivation was
performed on Mueller Hinton sheep blood (MH) agar (Oxoid) or in NZCYM
broth (Roth, St. Leon-Roth, Germany) [14, 24].
Isolation, propagation and purification of campylophages
Data on the campylophages used in this study are summarized in Table 1. The
majority of the phages (CP1, CP7, CP14, CP21, CP68) was isolated from chicken
faecal samples of organic farms in Berlin (Germany) and surroundings. To recover
phage particles, faecal samples were suspended in 10 ml SM-buffer (100 mM
NaCl, 8 mM MgSO4 7H2O, 50 mM Tris-Cl (1 M, pH 7.5)) on a stirrer.
Thereafter, the solution was centrifuged at 10,0006g followed by filtration
through a 0.2 mm nitrocellulose membrane (VWR International, Darmstadt,
Germany). Phage activity was detected by spotting dilutions of the filtrate onto
lawns of the C. jejuni reference strains NCTC11168, NCTC12662 and C. coli
NCTC12668 [25].
Some other group II and group III phages of this study have already been
described. Group III phage CP81 was recovered from a retail chicken portion
purchased from a supermarket in Bavaria (Germany). This phage has been
characterized in detail [23]. F14 and CP32 were obtained from phage typing sets
of Denmark [24] and the UK [26], respectively. The previously characterized
group II phages NCTC12675, NCTC12683 and NCTC12684 obtained from the
NCTC were included in the study [25]. All phages were purified by a three-fold
recovery of single plaques. High-titre lysates (.108 pfu/ml) of the phages were
obtained by infecting 1,000 ml cultures of the host strain (A600 of ,0.3) with
phages at a MOI of ,0.01. After 24 h, lysates were centrifuged for 30 min at
10,0006g to remove debris and then filtrated. Phages were concentrated by
ultracentrifugation and purified by CsCl step gradients [27]. Plaque assays, single
plaque isolations, and propagation of the phages were performed as previously
described [24]. The C. coli strain NCTC12668 and C. jejuni strain NCTC11168
were used for phage propagation and plaque assays of group II and group III
campylophages, respectively [25]. All phages used in this study were analysed by
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PFGE, restriction analysis and Southern hybridization demonstrating that the
members of each group were closely related (data not shown).
Host range determination
A total of 255 Campylobacter spp. strains (C. jejuni, 227 isolates; C. coli, 18 isolates;
C. lari, five isolates; C. fetus, two isolates; C. sputorum, two isolates and C.
hyointestinales, one isolate) of diverse environmental and clinical origin were used
for host range studies. The strains represented more that 20 different MLST types.
The host range of the phages was determined by activity assays. 400 ml of the
respective indicator strains were mixed with 6 ml prewarmed NZCYM softagar
(0.6%) and poured onto a LB agar plate. 10 ml aliquots of the diluted lysates were
spotted onto the solid overlay agar. Plates were incubated overnight at 42 C˚ for
24 h under microaerobic conditions [24].
Stability assays
The stability of the campylophages was investigated at pH values between 4 and 11
and at temperatures between 4 C˚ and 70 C˚. All stability assays were performed in
triplicate.
Phage lysates with adjusted titers of 108 pfu/ml were added to buffer having the
respective pH value. The pH of the phage lysate was adjusted at 20 C˚ with glycine
Table 1. Campylobacter strains and phages used in this study.
Strain Description Origin Reference
C. jejuni NCTC11168 Group III phage indicator and propagation strain Chicken NCTC [25]
C. jejuni NCTC12662 Propagation strain of group II phages CP7 and CP75 Unknown NCTC [25]
C. coli NCTC12668 Group II phage indicator and propagation strain Unknown NCTC [25]
C. jejuni BfR-CA-3871 Susceptible to group II and -III phages Sheep (CNET60) BfR (NRL Campylobacter)
C. jejuni BfR-CA-4014 Susceptible to group II and -III phages Wild bird (CNET28) BfR (NRL Campylobacter)
Group II phages
CP07 Myovirus, active on C. jejuni, C. coli Faecal sample, poultry, Germany This work
CP21 Myovirus, active on C. jejuni, C. coli Faecal sample, poultry, Germany [35]
CP68 Myovirus, active on C. jejuni, C. coli Faecal sample, poultry, Germany This work
CP75 (NCTC12675) Myovirus, active on C. jejuni, C. coli UK NCTC [25]
CP83 (NCTC12683) Myovirus, active on C. jejuni, C. coli UK NCTC [25]
CP84 (NCTC12684) Myovirus, active on C. jejuni, C. coli UK NCTC [25]
Group III phages
CP1 Myovirus, active on C. jejuni Faecal sample, poultry, Germany This work
CP14 Myovirus, active on C. jejuni Faecal sample, poultry, Germany This work
F14 Myovirus, active on C. jejuni Denmark [24]
CP32 Myovirus, active on C. jejuni UK [26]
CP81 Myovirus, active on C. jejuni Poultry skin, Germany [23]
NCTC; National Collection of Type Cultures, Health Protection Agency, UK.
doi:10.1371/journal.pone.0114785.t001
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hydrochloride (to pH 4.0); citric acid-(di) sodium hydrogen phosphate buffer (to
pH 5.0 and 6.0), Tris-HCl (to pH 7.0) or glycine-sodium hydroxide (to pH 8.0 to
11.0). For the test, 900 ml of the adjusted buffer solutions were supplemented with
100 ml of phage lysate, mixed and incubated at 20 C˚ for 24 h and 48 h. Thereafter,
aliquots of the buffered lysates were used to determine phage activity. To
minimize effects of the pH on the adsorption of phages, only 1021 to 1026
dilutions of the lysates were used for the analysis.
For temperature stability assays, phage lysates (108 pfu/ml) were incubated in a
thermomixer at time intervals as indicated. Stability of the phages at 220 C˚ was
determined by incubation of lysates (NZCYM broth without cryoprotectant) in a
freezer. Thereafter, the phage titer was determined by spotting dilutions onto
NZCYM softagar overlay plates.
Reduction of Campylobacter in vitro
For the experiments on in vitro reduction of Campylobacter, C. jejuni strain BfR-
CA-3871 (designated as 3871 throughout this manuscript) was used. Bacteria were
cultivated for 24 h as stated above. The cultures were adjusted with NZCYM broth
to an adsorption (A600) of 0.3 corresponding ,56107 cells/ml) and incubated
under microaerobic atmosphere. Single phages or cocktails of campylophages
were added to the cultures at MOIs (multiplicities of infection) as given in the
manuscript. The bacterial titer was determined in time intervals as stated by
plating 100 ml aliquots of a ten-fold dilution series on Mueller Hinton sheep blood
agar plates.
Based on their in vitro reduction efficacy on C. jejuni 3871, two group III
(CP14 and CP81) and one group II (CP68) phage were selected for the animal
trial (second trial, see below).
Ethics statement
The animal study (short title: Campylobacter reduction) was approved by the local
ethic commitee of the state Berlin (Landesamt fu¨r Gesundheit und Soziales,
Berlin, Germany) under the accession number G 0269/10.
Animal experiments
For both animal trials, one-day old male Vrolix chicks provided by Aviagen
GmbH (Hilbersdorf, Germany) from a Campylobacter-free hatchery were
transferred to the animal facility of the Federal Institute for Risk Assessment
(BfR). After ten days, chickens were randomly allocated to groups according to
the study design. It has been reported that transmission of infectious agents
between co-housed animals can modify the observed dose-response relationship
with implications for the estimation of the infectious dose and the comparison
between different agents and treatments [28]. However, in our study the chicken
were inoculated with 107 cfu of Campylobacter, which much exceeds the minimal
infectious dose and led to 100% colonized chicken before phage treatment.
Successive Phage Application for Efficient Reduction of C. jejuni
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Moreover, group housing better reflects real conditions in industrial chicken
farms, where coprophagy causes repeated exchange of infectious agents between
individual birds. Each group was kept in a room (4.86 m2) with a solid floor
bedded with wood shavings, provided with red light and a light regime of 13 h day
and 11 h night. Feed and water were provided ad libitum. Cloacal smears were
taken from all animals one week after arrival to confirm that they were
Campylobacter-free. This was carried out by incubation of the swabs in Preston
broth (Oxoid) for 24 h at 42 C˚ under microaerobic conditions. Following this,
bacteria were plated on mccDA agar (Oxoid) and incubated for 48 h under the
conditions described above. At day 20 of life, the birds were orally inoculated with
C. jejuni.
In the first animal trial, the colonization efficacy of two selected C. jejuni strains
(3871 and 4014, Table 1) was determined in two groups (A and B), each of which
comprising three birds. Chickens were orally inoculated with 107 cfu of C. jejuni
3871 (group A) and 4014 (group B). The colonization efficacy was determined by
Campylobacter enumeration in fecal samples after five, six and seven days of
infection.
The second animal trial was conducted to determine the potential of three
application strategies for the reduction of C. jejuni 3871. To ensure that the
experiment provides statistically reliable data, four groups (A to D) with ten
animals each were analysed. At day 20 of life, all birds were orally inoculated with
109 cfu/ml of C. jejuni 3871 suspended in CaCO3 to avoid inactivation of the
phages by the very low pH of the chicken digestive system [29]. On day 27, the
chicken from group B and D received orally a suspension of phage CP14
(5.06108 pfu), whereas group A remained untreated (control). The chicken of
group C received a suspension of the phages CP14 and CP81, each 5.06108 pfu.
On day 28, the animals of group D received a suspension of phage CP68
(5.061010 pfu).
Fecal samples were collected before phage application and then every 12 h,
starting on day 28 (24 h after administration). For this, chickens were separated in
cages for 30–60 minutes. When no faeces could be collected, chickens were
released and followed until defecation occurred. At day 31, all chickens were killed
by decapitation after exposition to electric current. Both ceca were dissected from
each animal. During the animal trials, all chickens were observed each day to
exclude any unnecessary suffering according to the guidelines of the German law
(TierSchG).
Enumeration of Campylobacter and isolation of cells for the
determination of phage resistance in vivo
Fecal samples of each chicken were used for the enumeration of Campylobacter at
different time points during the animal trial. One gram of sample was added to
9 ml of phosphate buffered saline (PBS) and used for the preparation of ten-fold
dilutions. 100 ml aliquots of each suspension were plated on Karmali agar
containing a Campylobacter selective supplement (Oxoid). Plates were incubated
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at 42 C˚ for 48 h under microaerobic conditions. After incubation, the number of
characteristic Campylobacter colonies was determined. Ten representative colonies
of each chicken were isolated and tested for phage-resistance. Each colony was
cultivated in NZCYM broth as stated above, mixed with 5 ml NZCYM softagar
(0.6%) and poured on LB agar. Ten-fold dilutions of CP14, CP81 and CP68
lysates were spotted onto the softagar to determine the phage susceptibility of the
isolates.
Statistical analyses
All statistical analyses were performed using the software Stata 13 (StatCorp.,
College Station, TX, USA). Statistical differences between the application groups
of the animal experiments were determined by use of the Wilcoxon Mann-
Whitney test, with a Bonferroni corrected alpha level of 0.05/350.0167 for
pairwise comparisons between the control group and the treatment groups (n53).
Results and Discussion
Selection of phages for the reduction of C. jejuni
To select phages that may be suitable for application, eleven group II (n56) and
group III (n55) phages (Table 1) were analysed in terms of their ability to lyse
255 Campylobacter spp. strains. In addition, the lytic properties of the phages were
determined. As shown in Table 2, all group III phages showed a similar host range
by lysing 21 to 26% out of 227 tested C. jejuni strains. Other Campylobacter
species were not infected. Within group II, two subgroups (A and B) disclosing
different host specificities were identified. Even though all group II phages were
able to infect both C. jejuni and C. coli strains, subgroup A phages CP68, CP75
and CP84 lysed nearly twice as many strains as the subgroup B phages CP7, CP21
and CP83 (Table 2). Some other authors reported higher percentages of
Campylobacter strains infected by single phages [14, 15, 17, 24]. However, in none
of these studies has such a high number of Campylobacter strains been
investigated. The obtained data demonstrate the importance of carefully
composed phage cocktails. To combat a broad range of C. jejuni and C. coli
strains, cocktails should contain group II as well as group III phages. While group
III phages infected higher numbers of C. jejuni strains than group II phages, C. coli
strains were exclusively lysed by phages belonging to group II. In addition, it has
to be taken into account that particularly group II phages can be very different
with respect to their host specificity. Thus, notably group II phages exhibiting a
broader host range (see subgroup A in Table 2) should be used for applications.
Infection of C. jejuni under in vitro conditions revealed a diverse lytic potential
of the investigated group III phages. Compared with the non-phage-treated
control, CP14 most efficiently (by approximately 3 log10 units) reduced the C.
jejuni 3871 counts at both applied MOIs of 0.1 and 10 after 24 h of incubation
(Fig. 1), whereas a reduction of only 1 log10 unit was achieved with the remaining
Successive Phage Application for Efficient Reduction of C. jejuni
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group III phages. A combined application of CP14 with other group III phages
(e.g. CP81) did not result in higher reductions (data not shown). The group II (A)
phages CP68, CP75 and CP84 showed very similar reduction rates and there were
no striking differences discernible at different MOIs or after (simultaneous or
successive) infection of the bacteria with two phages. In general, group II phages
caused slightly lower reductions than group III phages. However, cell lysis
occurred earlier (after 9 h) and remained constant for at least further 15 hours.
The data on group II and group III-induced cell lysis are in good agreement with
quantitative models of in vitro bacteriophage-host dynamics created by Cairns
et al. (2009) [30]. Similar to the published results obtained with group III phage
Table 2. Host range of group II and group III campylophages.
Group III phages Group II (A) phages Group II (B) phages
CP1 CP14 F14 CP32 CP81 CP68 CP75 CP84 CP7 CP83 CP21
Campylobacter spp. strains 1 255 255 255 255 255 255 255 255 255 255 255
Positive 56 51 59 50 47 31 30 34 19 15 17
% positive 22.0 20.0 23.1 19.6 18.4 12.2 11.8 13.3 7.5 5.9 6.7
C. jejuni 227 227 227 227 227 227 227 227 227 227 227
Positive 56 51 59 50 47 21 20 24 14 13 13
% positive 24.7 22.5 26.0 22.9 20.7 9.3 8.8 10.6 6.2 5.7 5.7
C. coli 18 18 18 18 18 18 18 18 18 18 18
Positive 0 0 0 0 0 10 10 10 5 2 4
% positive 0 0 0 0 0 55.6 55.6 55.6 27.8 11.1 22.2
1None of the other Campylobacter species: C. lari (n55), C. fetus (n52), C. sputorum (n52) and C. hyointestinales (n51) was lysed by the phages.
doi:10.1371/journal.pone.0114785.t002
Fig. 1. Reduction of C. jejuni 3871 by group III phages in vitro. Each experiment was performed in triplicate. For better clarity, only mean values without
standard deviations are shown.
doi:10.1371/journal.pone.0114785.g001
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CP8, no significant differences in the kinetics of cell lysis were observed with our
phages at MOIs of 0.1 and 10. Using an initial cell concentration of 56104 cfu/
ml, the required proliferation threshold of bacteria was exceeded while the
inundation threshold of phages was at maximum 56103 pfu/ml (Fig. 1).
In the last set of in vitro experiments, we compared CP14-induced C. jejuni
3871 cell lysis with the lytic activity of a combination of CP14 with a group II
phage (CP68 or CP75). Since group II phages cleared the host cell culture
significantly faster than group III phages (see above), they might be better suited
for a reduction of the bacteria shortly before slaughtering. For that reason, the
phages were added to the culture successively by adding the respective group II
phage at a high MOI of 10 18 h later than CP14. Similar to the experiments
before, CP14 lysed the bacteria efficiently (Fig. 2). The strongest reduction, related
to the control culture, was observed after 18 to 24 h of incubation. However,
while in the presence of CP14 alone, the cell number increased again by
approximately 1.3 log10 units between these time points, the addition of group II
phage CP68 resulted in an approximately 0.5 log10 units lower cell number after
24 h (Fig. 2). By contrast, neither a cocktail composed of CP14 and CP75 nor the
simultaneous application of CP14 and CP68 led to a higher reduction than those
achieved with CP14 alone. The reason for this result remains unknown. While
phage-induced lysis of Campylobacter under in vitro conditions has already been
reported by other authors [31, 32], this is the first study in which the kinetics of
host cell lysis induced by group II and group III phages has been compared.
Moreover, a combined action of a group II and a group III phage has not been
demonstrated before. The obtained data indicate that it might be conducive to use
low numbers of group III phages for longer incubation times allowing phage
replication while group II phages applied at high MOIs might be better suited for
‘‘lysis from without’’, the phenomenon of lysis caused by adsorption of numerous
phages to each cell. To elucidate whether the period needed for DNA replication,
packaging and virion assembly or the number of released particles account for the
different lysis times, the latent period and burst size of some of the phages was
determined. All of them revealed a similar latent period between 67 and 82 min,
which corresponds well with data determined for some other group II phages
[14]. Though, the burst size of group II phage CP68 was more than twice as large
(14 to 20 pfu) than those of the group III phages CP14 (6 to 7 pfu) and CP81 (4
to 6 pfu) (data not shown). Values between 9 and 24 pfu have also been reported
for group II phages in the study cited above. The data suggest that the fast lysis of
bacterial cultures induced by group II phages is mainly caused by their high burst
size.
Stability of the phages
Incubation of the eleven tested phages at temperatures between 4 C˚ and 70 C˚ for
8 h revealed that they are similarly stable. At temperatures up to 40 C˚, the phages
remained fully active while higher temperatures caused a gradual loss of activity
(Fig. 3). The long-term stability of the phages was studied for up to three years.
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Storage at 4 C˚ and 25 C˚ resulted in a decrease of activity by approximately 1 log10
unit after one year and by two to three log10 units at the end of the experiment
(after three years). Freezing at 220 C˚ decreased the phage titer by four and seven
log10 units after one and two years of incubation, respectively, whereas no activity
was detectable after three years.
The phages remained fully active for at least 2 h at pH values between pH 5 and
pH 9 (data not shown) and for at least 48 h at pH values between pH 7 and pH 9
at room temperature (Fig. 3). For group II phage CP220, an extended pH stability
has been reported [15]. To ensure protection from the low pH of the chicken
digestive system, the birds were fed with 1 ml of 30% CaCO3 solution before
phages were administered.
Animal experiments
In the first experiment (pre-trial), the capability of two C. jejuni strains (3871 and
4014, Table 1) to colonize the chicken gut was investigated (see Material and
Methods). The strains had previously shown sensitivity to group II and group III
phages under in vitro conditions. In addition, the in vivo stability of phages in the
absence of Campylobacter was studied after administration to two other groups of
animals (data not shown). Both Campylobacter strains colonized the chickens
efficiently. After administration of 107 cfu to 20 day-old birds, bacteria were
identified in excreta of all animals. While cell numbers between 3 and 5.3 log10
cfu/g of intestinal content were determined at 48 h, the numbers increased up to
7.7 log10 cfu/g at day 26. On day 27, the chickens were killed and Campylobacter
counts between 7.6 and 8.5 log10 cfu/g were determined in the caecum. Strain
Fig. 2. Reduction of C. jejuni 3871 in vitro by simultaneous and successive application of group II and group III phages. Each experiment was
performed in triplicate. For better clarity, only mean values without standard deviations are shown.
doi:10.1371/journal.pone.0114785.g002
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Fig. 3. pH and temperature stability of the phages CP14, CP81 and CP68. Each experiment was performed in triplicate. Bars indicate standard
deviations. pH stability was tested at 20˚C. As indicator strain for phage activity (quantified as PFU/ml), C. jejuni 3871 was used. Arrows indicate the initial
phage titers.
doi:10.1371/journal.pone.0114785.g003
Successive Phage Application for Efficient Reduction of C. jejuni
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3871 generally showed slightly higher rates of colonization than strain 4014 and
was therefore selected for the phage treatment. Unlike the bacterial strains, the
administered phages could not be identified in excreta and in the caecum of the
birds. It can be surmised that the number of applied phages (107 pfu) was too low
to detect them. Moreover, phage propagation within the chicken intestine could
not occur due to the absence of a suitable host. A strong decrease of phage titer by
several orders of magnitude has also been observed in an experiment where 1010
phages were administered to Campylobacter-free chickens [18].
Based on the in vitro data and the results achieved in the pre-trial, the main
animal experiment was designed. The following questions should be answered (i)
Is a simultaneous application of two group III phages more efficient than the
administration of a single (group III) phage? (ii) How is the efficacy of a
successive application of a group III and a group II phage? To answer these
questions, C. jejuni strain 3871 (107 cfu) was administered to four groups (A to
D) of 20 days old chickens (A: 9 animals, B to D: 10 animals each) (Fig. 4A). On
day 27 group B and group D received a dose of phage CP14 (MOI 0.1) while
group C got a cocktail comprising the phages CP14 and CP81, both of which
administered at a MOI of 0.1. Even though this cocktail did not perform better
than CP14 alone under in vitro conditions, the combined activity of two phages
might be beneficial in the chicken gut. On day 28, group D received an additional
dose of phage CP68 at a MOI of 10. The last group (A) of animals served as
control and did not get any phage. From day 27 to day 31 excreta of the birds were
collected in time intervals of 12 h and Campylobacter and phage counts were
determined. On day 31 all chickens were killed and caecal contents were analysed.
Fig. 4 summarizes the results on Campylobacter reduction. The data show that,
compared to the control, group III phage CP14 (experimental group B) caused a
statistically significant reduction from 48 h onwards with a maximal
Campylobacter decline (more than one log10 unit) after 72 h (p50.0137). In some
other studies with group III phages, the highest reduction was already observed
after 24 to 48 h [14, 15, 17, 18]. However, the collected data can be hardly
compared since the numbers of administered bacteria, phages and the resulting
MOIs were not the same. The concurrent administration of a second group III
phage (CP81, experimental group B) did not yield a significant reduction of
Campylobacter (p50.121). It is conceivable that there was a yet unknown
interference between CP14 and CP81 which inhibited phage propagation or that
CP81 induced resistance which also affected CP14 (see below). In the in vitro
experiments a cocktail of both phages significantly reduced Campylobacter counts
by up to 3 log10 units (data not shown). Hence it remains open why no reduction
was attained in chickens. Consistently, Wagenaar et al. (2005) reported that an
application of two group III phages led to a similar reduction (1.5 log10 units) of
C. jejuni as a single phage [18]. The authors could not detect any antagonistic
effect under in vitro conditions.
In our study the by far highest reduction was achieved by a combined action of
group III phage CP14 and group II phage CP68 that had been administered
successively (Fig. 4B). 48 h after application of the second phage CP68, a more
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than 3 log10 units lower number of Campylobacter was determined compared to
the untreated control (p50.0111). Even though bacterial counts increased again
until the end of the experiment, they remained significantly lower than in the
control group and in group B which had been exclusively treated with CP14. We
suspect that the fast cell lysis and high burst size of CP68 in conjunction with its
from CP14 divergent host cell receptor were mainly responsible for the increased
lytic activity observed in experimental group D.
Fig. 4. Design and outcome of the animal experiment. A. Time scale of the experiment. B. Reduction of C. jejuni in the chickens. Mean values of
Campylobacter counts (CFU/g feces) and standard deviations are shown.
doi:10.1371/journal.pone.0114785.g004
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Phage resistance of C. jejuni 3871 in vivo and in vitro
As resistance is of great importance for the outcome of phage application, we
analysed both the susceptibility of the bacteria under in vivo and under in vitro
conditions. Therefore, ten colonies isolated from the caecum of each bird were
analysed in terms of their susceptibility to CP14, CP81 and CP68. Table 3
illustrates that resistance of all isolates against group II phage CP68 was rather low
with frequencies between 1.0 and 2.0%. By contrast, the group III phages
provoked higher rates of resistance against themselves. Most notably, frequencies
of 7 and 8% were determined in group C, in which both group III phages were
applied. As the administration of CP14 alone (group B) yielded resistance
frequencies of only 5% (CP14) and 4% (CP81), it might be concluded that the
elevated levels of resistance observed in group C were mainly caused by CP81.
This could explain why Campylobacter counts were not reduced in group C. The
in vivo data on phage resistance were corroborated by in vitro experiments (see
Materials and Methods). Colonies that were resistant to a particular phage showed
also resistance to all other phages of the same group but not to phages belonging
to the other group. In addition, resistance to group II phages was much more
stable than resistance to phages of group III, which in some cases quickly reverted
to susceptibility, as already reported by Fischer et al. (2013) and Scott et al. (2007)
[33, 34]. Reversion to phage susceptibility can be caused by phase variable
capsular polysaccharide structures [22]. Even though several group III phages
investigated in the cited study were highly specific in the recognition of a
particular combination of capsular modifications, they caused cross-resistance.
Thus, it is advantageous to analyse resistance of all phages of a cocktail thoroughly
and to compose phages belonging to different groups, which differ in their host
ranges, lytic properties and resistance mechanisms.
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